| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 731806 | Null | 0.00109467026514912 | 0.30234106 |
| NSC 652809 | Null | 0.00119931827492062 | 0.72798957 |
| NSC 674225 | 2,7-Bis(methoxycarbonylmethyl)-10-methylphenothiazine | 0.00119931827492062 | 0.57757443 |
| NSC 684836 | Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- | 0.00119931827492062 | 0.32884407 |
| NSC 698959 | Null | 0.00119931827492062 | 0.27296973 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.00119931827492062 | 0.41479165 |
| NSC 756166 | GSK312948A | 0.00119931827492062 | 0.56836404 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.00119931827492062 | 0.59889965 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.00119931827492064 | 0.31917403 |
| NSC 623527 | Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt | 0.00119931827492064 | 0.14438742 |